Antlia Bioscience, Inc.
Doing business as Antlia Bioscience Inc.
- UEI
- QVE5F34K4773
- CAGE
- 8KY26
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- antliabio.com
- Founded
- 2021
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A novel long-acting conjugate of the vasodilative hormone, human brain natriuretic peptide (hbnp), to treat resistant… | National Heart Lung and Blood Institute | $786,628 |
Quick answers
What is Antlia Bioscience, Inc.'s UEI?
Antlia Bioscience, Inc.'s Unique Entity ID (UEI) in SAM.gov is QVE5F34K4773.
What is Antlia Bioscience, Inc.'s CAGE code?
Antlia Bioscience, Inc.'s CAGE code is 8KY26.
What is Antlia Bioscience, Inc.'s primary NAICS code?
Antlia Bioscience, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Antlia Bioscience, Inc. registered in SAM.gov?
Antlia Bioscience, Inc.'s SAM.gov registration expired on February 22, 2026.
What is Antlia Bioscience, Inc.'s most recent federal award?
Antlia Bioscience, Inc.'s most recent federal grant award is A novel long-acting conjugate of the vasodilative hormone, human brain natriuretic peptide (hbnp), to treat resistant… (R44HL169016), from National Heart Lung and Blood Institute, on September 19, 2024.
On GovTribe
See Antlia Bioscience, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors